Nisa Investment Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $84.1K | Sell |
7,485
-35,165
| -82% | -$395K | ﹤0.01% | 1448 |
|
2025
Q1 | $195K | Sell |
42,650
-131
| -0.3% | -$599 | ﹤0.01% | 1235 |
|
2024
Q4 | $241K | Buy |
42,781
+35,214
| +465% | +$199K | ﹤0.01% | 1241 |
|
2024
Q3 | $36.6K | Sell |
7,567
-147
| -2% | -$711 | ﹤0.01% | 1719 |
|
2024
Q2 | $37.6K | Buy |
7,714
+6,949
| +908% | +$33.9K | ﹤0.01% | 1742 |
|
2024
Q1 | $10.2K | Buy |
765
+107
| +16% | +$1.42K | ﹤0.01% | 2032 |
|
2023
Q4 | $9.17K | Sell |
658
-2,122
| -76% | -$29.6K | ﹤0.01% | 2057 |
|
2023
Q3 | $36.9K | Sell |
2,780
-40
| -1% | -$530 | ﹤0.01% | 1820 |
|
2023
Q2 | $52.9K | Buy |
2,820
+1,489
| +112% | +$27.9K | ﹤0.01% | 1737 |
|
2023
Q1 | $19K | Hold |
1,331
| – | – | ﹤0.01% | 2028 |
|
2022
Q4 | $26K | Sell |
1,331
-2
| -0.2% | -$39 | ﹤0.01% | 1981 |
|
2022
Q3 | $50K | Buy |
1,333
+233
| +21% | +$8.74K | ﹤0.01% | 1738 |
|
2022
Q2 | $17K | Buy |
+1,100
| New | +$17K | ﹤0.01% | 2092 |
|